Logo image of SHIM

SHIMMICK CORP (SHIM) Stock Fundamental Analysis

NASDAQ:SHIM - Nasdaq - US82455M1099 - Common Stock - Currency: USD

1.71  -0.03 (-1.72%)

Fundamental Rating

0

SHIM gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 49 industry peers in the Construction & Engineering industry. SHIM may be in some trouble as it scores bad on both profitability and health. SHIM has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year SHIM has reported negative net income.
SHIM had a negative operating cash flow in the past year.
SHIM Yearly Net Income VS EBIT VS OCF VS FCFSHIM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 -50M -100M -150M -200M

1.2 Ratios

The Return On Assets of SHIM (-29.93%) is worse than 91.49% of its industry peers.
The Return On Equity of SHIM (-9166.25%) is worse than 89.36% of its industry peers.
Industry RankSector Rank
ROA -29.93%
ROE -9166.25%
ROIC N/A
ROA(3y)3.16%
ROA(5y)N/A
ROE(3y)33.69%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SHIM Yearly ROA, ROE, ROICSHIM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 50 -50 -100 -150

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for SHIM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SHIM Yearly Profit, Operating, Gross MarginsSHIM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 0 -10 -20 -30

More info and screens

0

2. Health

2.1 Basic Checks

SHIM does not have a ROIC to compare to the WACC, probably because it is not profitable.
SHIM has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for SHIM is higher compared to a year ago.
SHIM Yearly Shares OutstandingSHIM Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M 15M 20M 25M
SHIM Yearly Total Debt VS Total AssetsSHIM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

SHIM has an Altman-Z score of 0.28. This is a bad value and indicates that SHIM is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of SHIM (0.28) is worse than 91.49% of its industry peers.
A Debt/Equity ratio of 35.25 is on the high side and indicates that SHIM has dependencies on debt financing.
With a Debt to Equity ratio value of 35.25, SHIM is not doing good in the industry: 89.36% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 35.25
Debt/FCF N/A
Altman-Z 0.28
ROIC/WACCN/A
WACC8.48%
SHIM Yearly LT Debt VS Equity VS FCFSHIM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 50M -50M

2.3 Liquidity

A Current Ratio of 0.80 indicates that SHIM may have some problems paying its short term obligations.
SHIM has a worse Current ratio (0.80) than 87.23% of its industry peers.
A Quick Ratio of 0.80 indicates that SHIM may have some problems paying its short term obligations.
SHIM has a worse Quick ratio (0.80) than 85.11% of its industry peers.
Industry RankSector Rank
Current Ratio 0.8
Quick Ratio 0.8
SHIM Yearly Current Assets VS Current LiabilitesSHIM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 100M 200M 300M

More info and screens

0

3. Growth

3.1 Past

SHIM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -166.60%.
SHIM shows a decrease in Revenue. In the last year, the revenue decreased by -4.73%.
EPS 1Y (TTM)-166.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-103.42%
Revenue 1Y (TTM)-4.73%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-5.37%

3.2 Future

The Earnings Per Share is expected to decrease by -17.91% on average over the next years. This is quite bad
The Revenue is expected to decrease by -6.97% on average over the next years.
EPS Next Y-573.4%
EPS Next 2Y-69.79%
EPS Next 3Y-17.91%
EPS Next 5YN/A
Revenue Next Year-27.2%
Revenue Next 2Y-13.4%
Revenue Next 3Y-6.97%
Revenue Next 5YN/A

3.3 Evolution

SHIM Yearly Revenue VS EstimatesSHIM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 200M 400M 600M
SHIM Yearly EPS VS EstimatesSHIM Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 -0.5 -1 -1.5 -2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SHIM. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SHIM. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SHIM Price Earnings VS Forward Price EarningsSHIM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SHIM Per share dataSHIM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

A cheap valuation may be justified as SHIM's earnings are expected to decrease with -17.91% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-69.79%
EPS Next 3Y-17.91%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SHIM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SHIMMICK CORP

NASDAQ:SHIM (3/7/2025, 8:00:02 PM)

1.71

-0.03 (-1.72%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)11-12 2024-11-12/bmo
Earnings (Next)03-27 2025-03-27/bmo
Inst Owners5.88%
Inst Owner Change-10.58%
Ins Owners0.47%
Ins Owner Change0%
Market Cap57.80M
Analysts45.71
Price Target3.06 (78.95%)
Short Float %2.31%
Short Ratio1.74
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)107.16%
Min EPS beat(2)-450.4%
Max EPS beat(2)664.71%
EPS beat(4)1
Avg EPS beat(4)-51.1%
Min EPS beat(4)-450.4%
Max EPS beat(4)664.71%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)3.57%
Min Revenue beat(2)-28.45%
Max Revenue beat(2)35.59%
Revenue beat(4)1
Avg Revenue beat(4)-3.5%
Min Revenue beat(4)-28.45%
Max Revenue beat(4)35.59%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.11
P/FCF N/A
P/OCF N/A
P/B 51.06
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.62
EYN/A
EPS(NY)-0.42
Fwd EYN/A
FCF(TTM)-2.97
FCFYN/A
OCF(TTM)-2.65
OCFYN/A
SpS15.23
BVpS0.03
TBVpS-0.18
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -29.93%
ROE -9166.25%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)3.16%
ROA(5y)N/A
ROE(3y)33.69%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover1.48
Health
Industry RankSector Rank
Debt/Equity 35.25
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 69.73%
Cap/Sales 2.11%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.8
Quick Ratio 0.8
Altman-Z 0.28
F-Score2
WACC8.48%
ROIC/WACCN/A
Cap/Depr(3y)42.05%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.07%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-166.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-103.42%
EPS Next Y-573.4%
EPS Next 2Y-69.79%
EPS Next 3Y-17.91%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.73%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-5.37%
Revenue Next Year-27.2%
Revenue Next 2Y-13.4%
Revenue Next 3Y-6.97%
Revenue Next 5YN/A
EBIT growth 1Y-5.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-607.42%
EBIT Next 3Y36.93%
EBIT Next 5YN/A
FCF growth 1Y-603.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2760.39%
OCF growth 3YN/A
OCF growth 5YN/A